TARS icon

Tarsus Pharmaceuticals
TARS

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$98
44% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Oppenheimer
Oppenheimer
Francois Brisebois
0% 1-yr TARS win rate
25 Feb ‘26 1 month ago
Guggenheim
Guggenheim
Eddie Hickman
67% 1-yr TARS win rate
25 Feb ‘26 1 month ago